|
Delayed
Nasdaq Stockholm
07:03:42 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.700 SEK | -0.93% |
|
+4.00% | -12.99% |
| 08-19 | Irlab's IRL757 is assigned the name linepemat by WHO | FW |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
EPS & Dividend: IRLAB Therapeutics AB
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.922 | 1 | -2.188 | -3.429 | -1.603 | -1.642 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 42.000 | 44.000 | 38.300 | 7.500 | 10.750 | 1.970 |
| Nbr of stocks (in thousands) | 51,748 | 51,748 | 51,868 | 51,868 | 51,868 | 84,938 |
| Announcement Date | 4/15/21 | 4/8/22 | 4/29/24 | 4/29/24 | 4/25/25 | 4/29/26 |
1SEK in Million2SEK
Estimates
Past dividends: IRLAB Therapeutics AB
| 2026-06-08 | Ex-dividend date - 0.97854 SEK | 00:00 |
Upcoming Events: IRLAB Therapeutics AB
| 2026-08-26 | Earnings release | Q2 2026 | 01:00 |
| 2026-08-26 | Earnings presentation | 04:00 | |
| 2026-11-13 | Earnings release | Q3 2026 | |
| 2027-02-11 | Earnings release | Annual 2026 | Day |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.55% | 0.61% | 35.55x | 22.67x | 12.84x | |
| 2.01% | 2.1% | 29.74x | - | - | |
| 2.62% | 2.75% | 33.42x | -366.75x | 7.74x | |
| 2.69% | 2.75% | 20.72x | 7.44x | 4.91x | |
| 2.76% | 2.88% | 22.47x | 6.32x | 5.78x | |
| 2.02% | 2.14% | 21.12x | 4.75x | 4.35x | |
| 2.33% | 2.46% | 27.43x | 20.73x | 7.09x | |
| 3.81% | 3.77% | 13.47x | 5.61x | 4.79x | |
| 2.3% | 2.37% | -43.83x | 9.76x | 6.34x | |
| Average | 2.34% | 2.43% | 17.79x | -36.19x | 6.73x | |
| Weighted average by Cap. | 1.91% | 2% | 25.34x | -42.01x | 8.43x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
